Piratoxin III (PrTX-III) is a phospholipase A 2 (PLA 2 , E.C. 3.1.1.4, phosphatide sn-2 acylhydrolase) isolated from Bothrops pirajai. Crystals of PrTX-III were obtained using the vapour-diffusion technique and X-ray diffraction data have been collected to 2.7 A Ê resolution. The enzyme was crystallized in the space group C2 with unit-cell parameters a = 60.88, b = 100.75, c = 48.19 A Ê , = 123.89 . A molecular-replacement solution of the structure has been found using bothropstoxin I from the venom of B. jararacussu as a search model.
Introduction
The genus Bothrops comprises several species which are widely distributed in South and North America. Among the bioactive proteins from Bothrops venoms, phospholipases A 2 appear as a major component. Phospholipases A 2 (PLA 2 , E.C. 3.1.1.4) are calcium-dependent enzymes which are responsible for the cleavage of the sn-2 ester bond of phospholipids (Deenen & de Haas, 1963) . They are found in most animal tissues, mainly in the pancreatic juices of mammals and the venoms of snakes and insects. The PLA 2 enzymes are believed to participate in cellular functions and cell signalling (Kudo et al., 1993) , as well as in the formation of several important metabolic precursors (e.g. in¯ammatory response mediators) derived from cleavage of the phospholipids (Siraganian, 1988) . These enzymes are classi®ed into four groups, according to their extracellular or intracellular origin, primary structure and disul®de-bond pattern (Heinrikson, 1990; Dennis, 1994) .
Class II PLA 2 s constitute a large part of the venom of many species of snake, such as rattlesnakes and vipers (Mebs & Samejima, 1986) . The enzymes belonging to this class can be subdivided into two distinct groups, according to enzymatic activity: the inactive group and the active group (Maraganore et al., 1984) . The enzymatically inactive PLA 2 s (K-49 PLA 2 , PLA 2 -like myotoxins) are PLA 2 s which exhibit low or no phospholipid cleavage activity. This is thought to arise from a substitution of the aspartate residue at position 49, the side chain of which is important in the binding of calcium ions (an essential cofactor), by a lysine residue (Holland et al., 1990; Scott et al., 1992; Arni et al., 1995) . However, despite the low or lack of enzymatic activity, K-49 PLA 2 s exhibits several different pharmacological activities, such as post-synaptic neurotoxicity, oedema formation (Gutie Â rrez & Lomonte, 1995) , myotoxicity (Lomonte et al., 1994) and liposome and membrane disruption (Dõ Âas et al., 1991; Ruf®ni et al., 1992) . The enzymatically active PLA 2 s (D-49 PLA 2 s) hydrolyse the sn-2 ester bond of 1,2-diacyl-3sn-phosphoglycerides. The D-49 PLA 2 s require calcium ion and are almost all at least 100 times more active when the substrate is condensed in micelles (Pieterson et al., 1974) or lamellar aggregates such as monolayers, vesicles and membranes (Slotboom et al., 1981) .
In this work, we present the crystallization and preliminary diffraction data of piratoxin III (PrTX-III) myotoxin. PrTX-III is a D-49 PLA 2 with moderate PLA 2 activity, myotoxic and anticoagulant activity. It was isolated from B. pirajai snake venom which was a kind gift from CEPIAC/CEPEC (Ministry of Agriculture, Bahia, Brazil). The enzymatically inactive K-49 PLA 2 piratoxin II (PrTX-II) from B. pirajai has previously been crystallized in our group and is currently in the process of structural re®nement (Lee et al., 1998) . Comparison of two (active and inactive) phospholipases from the same organism will provide us with more information on the structural differences and shed light on the activity of these proteins.
Protein puri®cation
PrTX-III was isolated and puri®ed from the whole venom of B. pirajai by reverse-phase and cation-exchange HPLC. 20 mg of whole venom were dissolved in 250 ml of 0.1%(v/v) tri¯uoroacetic acid. The resulting sample was centrifuged and the supernatant was applied to a 0.78 Â 30 cm u-Bondapack C-18 column (Waters 991 PDA system).
The puri®cation of the venom was performed with a linear gradient of 0±66%(v/v) acetonitrile in 0.1%(v/v) triuoroacetic acid at a¯ow rate of 2.0 ml min À1 crystallization papers
and was monitored at 280 nm. The PrTX-III fraction was lyophilized and dissolved in 0.05 M ammonium bicarbonate pH 7.4, centrifuged and applied to a 0.39 Â 7.8 cm Protein-Pack SP 5PW cation-exchange column, which had previously been equilibrated with the same buffer. Elution of PrTX-III was performed using a 0.05±1.0 M ammonium bicarbonate (pH 7.4) linear gradient. The chromatographic run was performed at a¯ow rate of 1.0 ml min À1 and was monitored at 280 nm. The puri®ed sample was lyophilized and used for crystallization trials.
Crystallization and data collection
Preliminary screening of the crystallization conditions was performed using a sparsematrix screen at 291 K (Crystal Screens I and II, Hampton Research). Lyophilized PrTX-III was initially dissolved to a concentration of 10 mg ml À1 in water and used in the screening procedure. Small crystals were found in condition number 40 of the Crystal Screen I kit (20% 2-propanol, 20% PEG 4000, 0.1 M sodium citrate pH 5.6). A search for re®ned crystallization conditions was then performed. New crystals were grown at 291 K using the hanging-drop vapour-diffusion technique by mixing equal volumes (1 ml) of a protein solution concentrated to 5 mg ml À1 with a reservoir solution which contained 19% 2-propanol, 20% PEG 4000 and 0.1 M sodium citrate pH 5.5. Plate-like crystals measuring 0.1 Â 0.1 Â 0.02 mm appeared in 10±15 d. X-ray diffraction data were collected at the protein crystallography beamline Polikarpov, Perles et al., 1998) at the Laborato Â rio Nacional de Luz Sõ Âncrotron (LNLS), Campinas, Brazil. The images were recorded using a MAR 345 image plate and synchrotron radiation of wavelength 1.38 A Ê . 110 oscillation images were collected corresponding to a total rotation of 132 . The collected images were processed and scaled with DENZO and SCALEPACK (Otwinowski, 1993) . The crystals belong to the space group C2 with unit-cell parameters a = 60.88, b = 100.75, c = 48.19 A Ê , = 123.89 . Data-set statistics are given in Table 1 .
Calculations using the Matthews coef®cient (Matthews, 1968) suggested the presence of two molecules per asymmetric unit (V m = 2.84 A Ê 3 Da À1 ). The crystal structure of PrTX-III was solved by the molecular-replacement method using the program AMoRe (Navaza, 1994) . Several molecular-replacement search models were tested. The best solution was found with the most homologous PLA 2 available in the main databases (all non-redundant GenBank CDS translations, PDB, Swissprot, PIR and PRF), bothropstoxin I from B. jararacussu, which displayed 65% primary sequence identity with PrTX-III. The atomic coordinate ®le of bothropstoxin I was kindly provided by the authors (Da Silva-Giotto et al., 1998) . The two most signi®cant rotationsearch solutions [correlation coef®cients (CC) of 23.5 and 21.9%] were used for the translation search using re¯ections in the resolution range 10±2.7 A Ê . The best solution of the translation search (CC = 43.1%; R factor = 49.2%) was subjected to ten cycles of rigid-body re®nement against all data between 10 and 2.7 A Ê resolution (®tting function of AMoRe). The ®tting yielded a solution with a correlation coef®cient of 49.8% and an R factor of 48.1%. The crystal packing was inspected using the program O (Jones & Kjeldgaard, 1993) and did not show any crystallographic or non-crystallographic clashes. Initial re®nement steps were performed using the maximum-likelihood method as implemented in the program REFMAC (Murshudov et al., 1997) . At present, the R factor of the model is 31.3% and R free is 38.6%. Further modelbuilding and re®nement steps are under way. 
